| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/11/2010 | US20100035362 Bio-silica chip comprising silica binding protein and method for fabricating the same |
| 02/11/2010 | US20100035361 Two helix binders |
| 02/11/2010 | US20100035340 Variants of human taste receptor genes |
| 02/11/2010 | US20100035339 Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor |
| 02/11/2010 | US20100035314 Method for the enzymatic production of 2-hydroxy-2-methyl carboxylic acids |
| 02/11/2010 | US20100035299 Methods for the purification of polypeptide conjugates |
| 02/11/2010 | US20100035289 Diagnosis and risk stratification by means of the novel marker ct-proadm |
| 02/11/2010 | US20100035280 Chimeric Fc-gamma Receptor and Method for Determination of ADCC Activity by Using the Receptor |
| 02/11/2010 | US20100035271 Modification of Collagenous Materials and Medical Treatment, Diagnosis and Monitoring of Fibrotic Conditions |
| 02/11/2010 | US20100035256 Enduracidin biosynthetic gene cluster from streptomyces fungicidicus |
| 02/11/2010 | US20100035237 Novel antigen constructs useful in the detection and differentiation of antibodies to hiv |
| 02/11/2010 | US20100035236 Enrichment method for variant proteins with altered binding properties |
| 02/11/2010 | US20100034908 Porphyromonas gingivalis polypeptides and nucleotides |
| 02/11/2010 | US20100034852 Methods and compositions for predicting and treating drug resistant strains of influenza virus |
| 02/11/2010 | US20100034846 Novel method for treating h.pylori infections |
| 02/11/2010 | US20100034845 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans; polynucleotide consisting of the nucleotide sequence of the ORF2 gene of an avian hepatitis E virus or its complementary strand |
| 02/11/2010 | US20100034842 Compositions Employing Alternative Reading Frame Polypeptides for the Treatment of Cancer and Infectious Disease |
| 02/11/2010 | US20100034837 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds |
| 02/11/2010 | US20100034822 Haemophilus Influenzae Type B |
| 02/11/2010 | US20100034817 Compositions and methods for the treatment of immune related diseases |
| 02/11/2010 | US20100034805 Kallikrein-inhibitor therapies |
| 02/11/2010 | US20100034789 Novel carbosilane dendrimers, preparation method thereof and use of same |
| 02/11/2010 | US20100034776 Replication-competent anti-cancer vectors |
| 02/11/2010 | CA2735710A1 Sting (stimulator of interferon genes), a regulator of innate immune responses |
| 02/11/2010 | CA2733589A1 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity |
| 02/11/2010 | CA2733518A1 Treatment or prevention of hepatitis c with immunomodulator compounds |
| 02/11/2010 | CA2733506A1 Biological applications of steroid binding domains |
| 02/11/2010 | CA2733461A1 Methods of predicting cancer lethality using replikin counts |
| 02/11/2010 | CA2733425A1 Vaccines against clostridium difficile and methods of use |
| 02/11/2010 | CA2733104A1 Optimized promoter sequence |
| 02/11/2010 | CA2733059A1 Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides |
| 02/11/2010 | CA2733057A1 Modulation of toll-like receptor 3 expression by antisense oligonucleotides |
| 02/11/2010 | CA2733006A1 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal |
| 02/11/2010 | CA2733005A1 Truncated analogues of glucose-dependent insulinotropic polypeptide |
| 02/11/2010 | CA2732973A1 Glucose-dependent insulinotropic polypeptide analogues |
| 02/11/2010 | CA2732949A1 Analogues of glucose-dependent insulinotropic polypeptide |
| 02/11/2010 | CA2732802A1 Modulation of toll-like receptor 8 expression by antisense oligonucleotides |
| 02/11/2010 | CA2732799A1 Modulation of toll-like receptor 7 expression by antisense oligonucleotides |
| 02/11/2010 | CA2732449A1 Fgfr extracellular domain acidic region muteins |
| 02/11/2010 | CA2732283A1 Immunity-inducing agent |
| 02/11/2010 | CA2731438A1 Anti-pancreatic cancer antibodies |
| 02/10/2010 | EP2151507A1 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 02/10/2010 | EP2151495A1 Hcv gene |
| 02/10/2010 | EP2151493A1 Host cells containing multiple integrating vectors |
| 02/10/2010 | EP2151454A2 Platelet-derived growth factor D, DNA coding therefor, and uses thereof |
| 02/10/2010 | EP2151453A1 C-met kinase binding proteins |
| 02/10/2010 | EP2151452A1 Bag-1 peptide that inhibits prostate cancer |
| 02/10/2010 | EP2151244A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/10/2010 | EP2150819A1 S100a9 interaction screening method |
| 02/10/2010 | EP2150618A1 Il-12 immunotherapy for cancer |
| 02/10/2010 | EP2150613A1 Mutant reoviruses and methods of making and using |
| 02/10/2010 | EP2150561A1 Demannosylated recombinant factor vii for the treatment of patients with haemophilia a |
| 02/10/2010 | EP2150560A1 Methods and compositions for modulating bmp-10 activity |
| 02/10/2010 | EP2150559A2 Increased production of a target product via stabilization of mrna |
| 02/10/2010 | EP1711520B1 Polypeptides for the diagnosis and therapy of leishmaniasis |
| 02/10/2010 | EP1532261B1 Methods and dna constructs for high yield production of polypeptides |
| 02/10/2010 | EP1383924B1 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof |
| 02/10/2010 | EP0910655B1 Vaccines for treatment of lymphoma and leukemia |
| 02/10/2010 | CN101646687A Method of producing methionine in corynebacteria by over-expressing enzymes of the pentose phosphate pathway |
| 02/10/2010 | CN101643732A A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 02/10/2010 | CN101643512A Novel immunoadhesin for the prevention of rhinovirus infection |
| 02/10/2010 | CN101643506A Preparation of monoclonal antibody of specific combined sibutramine and demethylated sibutramine |
| 02/10/2010 | CN101643505A Nitrofuran compound and preparation method and application thereof |
| 02/10/2010 | CN101643504A Exendin 4 analogue |
| 02/10/2010 | CN101643503A Neutrophil-activating peptide 2 (72) taken as primary liver cancer markers and application thereof |
| 02/10/2010 | CN101643502A Plant factor and application thereof in fertilizer |
| 02/10/2010 | CN101643501A Novel antibiotic and nucleotide sequence, preparation method and application thereof |
| 02/10/2010 | CN101643500A Asia I synthetic peptide vaccine of foot and mouth disease |
| 02/10/2010 | CN100588661C Process for preparing recombined placental growth factor |
| 02/10/2010 | CN100588660C Antigenic determinant of SARS coronavirus nucleocapsid protein and application thereof |
| 02/09/2010 | US7660677 Method of designing physiologically active peptide and use thereof |
| 02/09/2010 | US7659462 Plants and seeds of hybrid corn variety CH862061 |
| 02/09/2010 | US7659461 Plants and seeds of hybrid corn variety CH039640 |
| 02/09/2010 | US7659448 Plant regulatory sequences for selective control of gene expression |
| 02/09/2010 | US7659447 Increasing host plant susceptibility to agrobacterium infection by overexpression of the arabidopsis VIP1 gene |
| 02/09/2010 | US7659446 Transgenic plants having increased soluble solids, lycopene, and improved plant volume or yield, increased anthocyanin in leaves, seedling vigor; improved resistance to cold, heat, freezing, low nitrogen and phosphorus conditions, osmotic stresses such as drought, and high salt |
| 02/09/2010 | US7659441 CD9/CD81 double-deficient non-human animal |
| 02/09/2010 | US7659387 Transgenic mammals introduced a Period 1 promoter that confers rhythmical expression |
| 02/09/2010 | US7659385 Polynucleotides encoding molecules designated LDCAM |
| 02/09/2010 | US7659380 Method of isolation and purification of trypsin from pronase protease and use thereof |
| 02/09/2010 | US7659379 Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency |
| 02/09/2010 | US7659375 Interleukin specific immunoglobulin for prevention and treatment of vision, autoimmune, inflammatory and diabetic disorders |
| 02/09/2010 | US7659373 Producing such EPO products characterized by a high proportion of N-acetyl-lactosamine units or/and tetraantennary branches in the carbohydrate structure |
| 02/09/2010 | US7659371 Patched polypeptides and uses related thereto |
| 02/09/2010 | US7659370 Nervous system protein for use in treatment and prevention of nervous system and seizure disorders |
| 02/09/2010 | US7659369 Enzymatic polypeptide for use as diagnostic tool in screening parasiticides |
| 02/09/2010 | US7659368 ErbB2 and ErbB3 chimeric heteromultimer adhesins |
| 02/09/2010 | US7659367 Contains insulin-like growth factor-I, insulin-like growth factor binding protein 3 and integrin-binding domain of vitronectin ; wound healing; surgical implant, prosthesis, scaffold, wound or burn dressing |
| 02/09/2010 | US7659365 Biodegradable homopolyamino acids and which can be used for the vectorization of active ingredients; cosmetic, dietetic or phytosanitaty; polylysine |
| 02/09/2010 | US7659363 Process for the preparation of insulin or an insulin derivative in the presence of oxygen |
| 02/09/2010 | US7659362 Metal-binding motif compositions and methods |
| 02/09/2010 | US7659251 Ligand for G-protein coupled receptor FPRL2 |
| 02/09/2010 | US7659250 BMP-7 variant compositions, methods and uses |
| 02/09/2010 | US7659249 Membrane-permeable NFAT inhibitory peptide |
| 02/09/2010 | US7659248 a solubilizing agent, an antioxidant, and a buffer; improved storage stability and oxidation resistance |
| 02/09/2010 | US7659247 Production of a von Willebrand factor preparation having a high specific activity |
| 02/09/2010 | US7659243 Treatment of ALS and variants thereof consisting of primary lateral sclerosis (PLS) or spinal muscular atrophy (SMA) |
| 02/09/2010 | US7659240 Mucin immobilized chromatography |
| 02/09/2010 | US7659117 Immunostimulatory fusion proteins comprising polypeptide antigen for generating protective DC-induced T-cell-mediated immune responses; metastatic cancers |
| 02/09/2010 | US7659116 Monoclonal antibody against frizzled receptor 4 |